These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 26092858)

  • 1. Comparison of the Pathogenesis of the Angola and Ravn Strains of Marburg Virus in the Outbred Guinea Pig Model.
    Cross RW; Fenton KA; Geisbert JB; Ebihara H; Mire CE; Geisbert TW
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S258-70. PubMed ID: 26092858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses.
    Swenson DL; Warfield KL; Larsen T; Alves DA; Coberley SS; Bavari S
    Expert Rev Vaccines; 2008 May; 7(4):417-29. PubMed ID: 18444889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling Marburg Virus Disease in Syrian Golden Hamsters: Contrasted Virulence Between Angola and Ci67 Strains.
    Cross RW; Fenton KA; Foster SL; Geisbert JB; Geisbert TW
    J Infect Dis; 2023 Nov; 228(Suppl 7):S559-S570. PubMed ID: 37610176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and characterization of a mouse model for Marburg hemorrhagic fever.
    Warfield KL; Bradfute SB; Wells J; Lofts L; Cooper MT; Alves DA; Reed DK; VanTongeren SA; Mech CA; Bavari S
    J Virol; 2009 Jul; 83(13):6404-15. PubMed ID: 19369350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine.
    Daddario-DiCaprio KM; Geisbert TW; Geisbert JB; Ströher U; Hensley LE; Grolla A; Fritz EA; Feldmann F; Feldmann H; Jones SM
    J Virol; 2006 Oct; 80(19):9659-66. PubMed ID: 16973570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against lethal Marburg virus infection mediated by lipid encapsulated small interfering RNA.
    Ursic-Bedoya R; Mire CE; Robbins M; Geisbert JB; Judge A; MacLachlan I; Geisbert TW
    J Infect Dis; 2014 Feb; 209(4):562-70. PubMed ID: 23990568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune Response to Marburg Virus Angola Infection in Nonhuman Primates.
    Fernando L; Qiu X; Melito PL; Williams KJ; Feldmann F; Feldmann H; Jones SM; Alimonti JB
    J Infect Dis; 2015 Oct; 212 Suppl 2():S234-41. PubMed ID: 25957966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virulence of Marburg Virus Angola Compared to Mt. Elgon (Musoke) in Macaques: A Pooled Survival Analysis.
    Blair PW; Keshtkar-Jahromi M; Psoter KJ; Reisler RB; Warren TK; Johnston SC; Goff AJ; Downey LG; Bavari S; Cardile AP
    Viruses; 2018 Nov; 10(11):. PubMed ID: 30469360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct Biological Phenotypes of Marburg and Ravn Virus Infection in Macaques.
    Nicholas VV; Rosenke R; Feldmann F; Long D; Thomas T; Scott DP; Feldmann H; Marzi A
    J Infect Dis; 2018 Nov; 218(suppl_5):S458-S465. PubMed ID: 30215737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and characterization of a guinea pig model for Marburg virus.
    Wong G; Cao WG; He SH; Zhang ZR; Zhu WJ; Moffat E; Ebihara H; Embury-Hyatt C; Qiu XG
    Zool Res; 2018 Jan; 39(1):32-41. PubMed ID: 29511143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and characterization of a lethal mouse model for the Angola strain of Marburg virus.
    Qiu X; Wong G; Audet J; Cutts T; Niu Y; Booth S; Kobinger GP
    J Virol; 2014 Nov; 88(21):12703-14. PubMed ID: 25142608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a model for marburgvirus based on severe-combined immunodeficiency mice.
    Warfield KL; Alves DA; Bradfute SB; Reed DK; VanTongeren S; Kalina WV; Olinger GG; Bavari S
    Virol J; 2007 Oct; 4():108. PubMed ID: 17961252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marburg virus infection in nonhuman primates: Therapeutic treatment by lipid-encapsulated siRNA.
    Thi EP; Mire CE; Ursic-Bedoya R; Geisbert JB; Lee ACH; Agans KN; Robbins M; Deer DJ; Fenton KA; MacLachlan I; Geisbert TW
    Sci Transl Med; 2014 Aug; 6(250):250ra116. PubMed ID: 25143366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex adenovirus-vectored vaccine protects guinea pigs from three strains of Marburg virus challenges.
    Wang D; Hevey M; Juompan LY; Trubey CM; Raja NU; Deitz SB; Woraratanadharm J; Luo M; Yu H; Swain BM; Moore KM; Dong JY
    Virology; 2006 Sep; 353(2):324-32. PubMed ID: 16820184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marburg virus Angola infection of rhesus macaques: pathogenesis and treatment with recombinant nematode anticoagulant protein c2.
    Geisbert TW; Daddario-DiCaprio KM; Geisbert JB; Young HA; Formenty P; Fritz EA; Larsen T; Hensley LE
    J Infect Dis; 2007 Nov; 196 Suppl 2(Suppl 2):S372-81. PubMed ID: 17940973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A hamster model for Marburg virus infection accurately recapitulates Marburg hemorrhagic fever.
    Marzi A; Banadyga L; Haddock E; Thomas T; Shen K; Horne EJ; Scott DP; Feldmann H; Ebihara H
    Sci Rep; 2016 Dec; 6():39214. PubMed ID: 27976688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-dependent enhancement of Marburg virus infection.
    Nakayama E; Tomabechi D; Matsuno K; Kishida N; Yoshida R; Feldmann H; Takada A
    J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S978-85. PubMed ID: 21987779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aerosol exposure to the angola strain of marburg virus causes lethal viral hemorrhagic Fever in cynomolgus macaques.
    Alves DA; Glynn AR; Steele KE; Lackemeyer MG; Garza NL; Buck JG; Mech C; Reed DS
    Vet Pathol; 2010 Sep; 47(5):831-51. PubMed ID: 20807825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Key genomic changes necessary for an in vivo lethal mouse marburgvirus variant selection process.
    Lofts LL; Wells JB; Bavari S; Warfield KL
    J Virol; 2011 Apr; 85(8):3905-17. PubMed ID: 21289122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection Against Marburg Virus Using a Recombinant VSV-Vaccine Depends on T and B Cell Activation.
    Marzi A; Menicucci AR; Engelmann F; Callison J; Horne EJ; Feldmann F; Jankeel A; Feldmann H; Messaoudi I
    Front Immunol; 2018; 9():3071. PubMed ID: 30723475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.